The global burden of tuberculosis mortality in children: a
mathematical modelling study
mathematical modelling study
File(s)PIIS2214109X17302899.pdf (326.17 KB)
Published version
Author(s)
Dodd, P
Yuen, C
Sismanidis, C
Seddon, JA
Jenkins, H
Type
Journal Article
Abstract
Background
Tuberculosis in children is increasingly recognised as an important component of the global tuberculosis burden, with an estimated 1 million cases in 2015. Although younger children are vulnerable to severe forms of tuberculosis disease, no age-disaggregated estimates of paediatric tuberculosis mortality exist, and tuberculosis has never been included in official estimates of under-5 child mortality. We aimed to produce a global mortality burden estimate in children using a complementary approach not dependent on vital registration data.
Methods
In this mathematical modelling study, we estimated deaths in children younger than 5 years and those aged 5–14 years for 217 countries and territories using a case-fatality-based approach. We used paediatric tuberculosis notification data and HIV and antiretroviral treatment estimates to disaggregate the WHO paediatric tuberculosis incidence estimates by age, HIV, and treatment status. We then applied systematic review evidence on corresponding case-fatality ratios.
Findings
We estimated that 239 000 (95% uncertainty interval [UI] 194 000–298 000) children younger than 15 years died from tuberculosis worldwide in 2015; 80% (191 000, 95% UI 132 000–257 000) of these deaths were in children younger than 5 years. More than 70% (182 000, 140 000–239 000) of deaths occurred in the WHO southeast Asia and Africa regions. We estimated that 39 000 (17%, 23 000–73 000) paediatric tuberculosis deaths worldwide were in children with HIV infections, with 31 000 (36%, 19 000–59 000) in the WHO Africa region. More than 96% (230 000, 185 000–289 000) of all tuberculosis deaths occurred in children not receiving tuberculosis treatment.
Interpretation
Tuberculosis is a top ten cause of death in children worldwide and a key omission from previous analyses of under-5 mortality. Almost all these deaths occur in children not on tuberculosis treatment, implying substantial scope to reduce this burden.
Tuberculosis in children is increasingly recognised as an important component of the global tuberculosis burden, with an estimated 1 million cases in 2015. Although younger children are vulnerable to severe forms of tuberculosis disease, no age-disaggregated estimates of paediatric tuberculosis mortality exist, and tuberculosis has never been included in official estimates of under-5 child mortality. We aimed to produce a global mortality burden estimate in children using a complementary approach not dependent on vital registration data.
Methods
In this mathematical modelling study, we estimated deaths in children younger than 5 years and those aged 5–14 years for 217 countries and territories using a case-fatality-based approach. We used paediatric tuberculosis notification data and HIV and antiretroviral treatment estimates to disaggregate the WHO paediatric tuberculosis incidence estimates by age, HIV, and treatment status. We then applied systematic review evidence on corresponding case-fatality ratios.
Findings
We estimated that 239 000 (95% uncertainty interval [UI] 194 000–298 000) children younger than 15 years died from tuberculosis worldwide in 2015; 80% (191 000, 95% UI 132 000–257 000) of these deaths were in children younger than 5 years. More than 70% (182 000, 140 000–239 000) of deaths occurred in the WHO southeast Asia and Africa regions. We estimated that 39 000 (17%, 23 000–73 000) paediatric tuberculosis deaths worldwide were in children with HIV infections, with 31 000 (36%, 19 000–59 000) in the WHO Africa region. More than 96% (230 000, 185 000–289 000) of all tuberculosis deaths occurred in children not receiving tuberculosis treatment.
Interpretation
Tuberculosis is a top ten cause of death in children worldwide and a key omission from previous analyses of under-5 mortality. Almost all these deaths occur in children not on tuberculosis treatment, implying substantial scope to reduce this burden.
Date Issued
2017-09-01
Date Acceptance
2017-06-29
Citation
Lancet Global Health, 2017, 5 (9), pp.e898-e906
ISSN
2214-109X
Publisher
Elsevier
Start Page
e898
End Page
e906
Journal / Book Title
Lancet Global Health
Volume
5
Issue
9
Copyright Statement
© The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Identifier
https://www.sciencedirect.com/science/article/pii/S2214109X17302899?via%3Dihub
Subjects
Science & Technology
Life Sciences & Biomedicine
Public, Environmental & Occupational Health
VERBAL AUTOPSY PROCEDURES
RESISTANT TUBERCULOSIS
CIVIL REGISTRATION
METAANALYSIS
THERAPY
Adolescent
Child
Child Mortality
Child, Preschool
Cost of Illness
Global Health
Humans
Infant
Infant, Newborn
Models, Theoretical
Tuberculosis
Humans
Tuberculosis
Child Mortality
Models, Theoretical
Cost of Illness
Adolescent
Child
Child, Preschool
Infant
Infant, Newborn
Global Health
0605 Microbiology
1117 Public Health and Health Services
Publication Status
Published
Article Number
e 898
Date Publish Online
2017-08-11